Cholera vaccination in Urban Haiti

American Journal of Tropical Medicine and Hygiene

Volumn 89, Issue 4, 2013, Pages 671-681

  Rouzier, Vanessa ^a,b,c,d   Severe, Karine ^a,b,c,d   Juste, Marc Antoine Jean ^a,b,c,d   Peck, Mireille ^a,b,c,d   Perodin, Christian ^a,b,c,d   Severe, Patrice ^a,b,c,d   Deschamps, Marie Marcelle ^a,b,c,d   Verdier, Rose Irene ^a,b,c,d   Prince, Sabine ^a,b,c,d   Francois, Jeannot ^a,b,c,d   Cadet, Jean Ronald ^a,b,c,d   Guillaume, Florence D ^a,b,c,d   Wright, Peter F ^a,b,c,d   Pape, Jean W ^a,b,c,d  

^a Department of Adolescent Medicine   (Haïti)

^b MINISTRY OF HEALTH AND POPULATION   (Haïti)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; SHANCHOL; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLERA; COMMUNITY CARE; DIARRHEA; DIZZINESS; DRUG SAFETY; DRUG TOLERABILITY; EPIDEMIC; FEMALE; GROUPS BY AGE; HAITI; HEADACHE; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PILOT STUDY; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; TREATMENT RESPONSE; URBAN AREA; VACCINATION; VOMITING; IMMUNOLOGY; INFANT; ORAL DRUG ADMINISTRATION; TIME; URBAN POPULATION;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHOLERA; CHOLERA VACCINES; DIARRHEA; FEMALE; HAITI; HUMANS; INFANT; MALE; TIME FACTORS; URBAN POPULATION; VACCINATION;

EID: 84886078203     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.13-0171     Document Type: Article

References (37)

1. Ali M, Lopez AL, You YA, Kim YE, Sah B, Maskery B, Clemens J, 2012. The global burden of cholera. Bull World Health Organ 90: 209-218.
2. Son MS, Megli CJ, Kovacikova G, Qadri F, Taylor RK, 2011. Characterization of Vibrio cholerae O1 El Tor biotype variant clinical isolates from Bangladesh and Haiti, including a molecular genetic analysis of virulence genes. J Clin Microbiol 49: 3739-3749.
3. Goodgame RW, Greenough WB, 1975. III Cholera in Africa: a message for the West. Ann Intern Med 82: 101-106.
4. Seas C, Miranda J, Gil AI, Leon-Barua R, Patz J, Huq A, Colwell RR, Sack RB, 2000. New insights on the emergence of cholera in Latin America during 1991: the Peruvian experience. Am J Trop Med Hyg 62: 513-517. (Pubitemid 32164761)
5. Centers for Disease Control and Prevention (CDC), 2010. Cholera outbreak-Haiti, October 2010. MMWR Morb Mortal Wkly Rep 59: 1411.
6. Chin CS, Sorenson J, Harris JB, Robins WP, Charles RC, Jean-Charles RR, Bullard J, Webster DR, Kasarskis A, Peluso P, Paxinos EE, Yamaichi Y, Calderwood SB, Mekalanos JJ, Schadt EE, Waldor MK, 2011. The origin of the Haitian cholera outbreak strain. N Engl J Med 364: 33-42.
7. Haiti Ministry of Public Health and Population. Available at: http://www.mspp.gouv.ht/site/index.php?option=com-content& view=article&id=120&Itemid=1. Accessed November 7, 2012.
8. Barzilay EJ, Schaad N,Magloire R,Mung KS, Boncy J, Dahourou GA, Mintz ED, Steenland MW, Vertefeuille JF, Tappero JW, 2013. Cholera surveillance during the Haiti epidemic: the first 2 years. N Engl J Med 368: 599-609.
9. Sullivan CA, Meigh JR, Giacomello AM, 2003. The Water Poverty Index: development and application at the community scale. Nat Resour Forum 27: 189-199. (Pubitemid 37124334)
10. Waldman RJ, Mintz ED, Papowitz HE, 2013. The cure for cholera: improving access to safe water and sanitation. N Engl J Med 368: 592-594.
11. Periago MR, Frieden TR, Tappero JW, De Cock KM, Aasen B, Andrus JK, 2012. Elimination of cholera transmission in Haiti and the Dominican Republic. Lancet 379: e12-e13.
12. Nelson EJ, Nelson DS, Salam MA, Sack DA, 2011. Antibiotics for both moderate and severe cholera. N Engl J Med 364: 5-7.
13. Ivers LC, Farmer PE, Pape WJ, 2012. Oral cholera vaccine and integrated cholera control in Haiti. Lancet 379: 2026-2028.
14. Ivers LC, Farmer P, Almazor CP, Leandre F, 2010. Five complimentary interventions to slow cholera. Haiti Lancet 376: 2048-2051.
15. Farmer P, Almazor CP, Bahnsen ET, Barry D, Bazile J, Bloom BR, Bose N, Brewer T, Calderwood SB, Clemens JD, Cravioto A, Eustache E, Je'rôme G, Gupta N, Harris JB, Hiatt HH, Holstein C, Hotez PJ, Ivers LC, Kerry VB, Koenig SP, Larocque RC, Le'andre F, Lambert W, Lyon E, Mekalanos JJ, Mukherjee JS, Oswald C, Pape JW, Gretchko Prosper A, Rabinovich R, Raymonville M, Ré jouit JR, Ronan LJ, Rosenberg ML, Ryan ET, Sachs JD, Sack DA, Surena C, Suri AA, Ternier R, Waldor MK, Walton D, Weigel JL, 2011. Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care. PLoS Negl Trop Dis 5: e1145.
16. Newton AE, Heiman KE, Schmitz A, Torok T, Apostolou A, Hanson H, Gounder P, Bohm S, Kurkjian K, Parsons M, Talkington D, Stroika S, Madoff LC, Elson F, Sweat D, Cantu V, Akwari O, Mahon BE, Mintz ED, 2011. Cholera in United States associated with epidemic in Hispaniola. Emerg Infect Dis 17: 2166-2168.
17. Ryan ET, Madoff LC, Ferraro MJ, 2011. Case records of the Massachusetts General Hospital. Case 20-2011. A 30-year-old man with diarrhea after a trip to the Dominican Republic. N Engl J Med 364: 2536-2541.
18. Shin S, Desai SN, Sah BK, Clemens JD, 2011. Oral vaccines against cholera. Clin Infect Dis 52: 1343-1349.
19. Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Han SH, Attridge S, Donner A, Ganguly NK, Bhattacharya SK, Nair GB, Clemens JD, Lopez AL, 2011. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis 5: e1289.
20. Sinclair D, Abba K, Zaman K, Qadri F, Graves PM, 2011. Oral vaccines for preventing cholera. Cochrane Database Syst Rev Mar 16 (3): CD008603.
21. Lucas ME, Deen JL, von Seidlein L, Wang XY, Ampuero J, Puri M, Ali M, Ansaruzzaman M, Amos J, Macuamule A, Cavailler P, Guerin PJ, Mahoudeau C, Kahozi-Sangwa P, Chaignat CL, Barreto A, Songane FF, Clemens JD, 2005. Effectiveness of a mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 352: 757-767. (Pubitemid 40271170)
22. Clemens JD, Ke NT, Thuy HT, Son ND, Canh DG, Hang PV, Rao MR, Trach DD, 1997. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. Lancet 349: 231-235. (Pubitemid 27050988)
23. Pape JW, Johnson WD Jr., Fitzgerald DW, 2010. The earthquake in Haiti: dispatch from Port-au-Prince. N Engl J Med 362: 575-577.
24. Pape JW, Deschamps MM, Ford H, Joseph P, Johnson WD Jr., Fitzgerald DW, 2010. The GHESKIO refugee camp after the earthquake in Haiti-dispatch 2 from Port-au-Prince. N Engl J Med 362: e27.
25. Pape JW, Rouzier V, Ford H, Joseph P, JohnsonWDJr., Fitzgerald DW, 2010. The GHESKIO field hospital and clinics after the earthquake in Haiti: dispatch 3 from Port-au-Prince. N Engl J Med 362: e34.
26. Ali M, Sur D, You YA, Kanungo S, Sah B, Manna B, Puri M, Wierzba TF, Donner A, Nair GB, Bhattacharya SK, Dhingra MS, Deen JL, Lopez AL, Clemens J, 2013. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India. Clin Infect Dis 56: 1123-1131.
27. PAHO Position on Cholera Vaccination in Haiti, 2010. Version October 27, 2010. Washington, DC: Pan American Health Organization.
28. World Health Organization, 2010. Cholera vaccines: WHO position paper. Wkly Epidemiol Rec 85: 117-128.
29. Date KA, Vicari A, Hyde TB, Mintz E, Danovaro-Holliday MC, Henry A, Tappero JW, Roels TH, Abrams J, Burkholder BT, Ruiz-Matus C, Andrus J, Dietz V, 2011. Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011. Emerg Infect Dis 17: 2105-2112.
30. The Task Force for Global Health/Partners in Health, 2012. Stop Cholera: Coalition for Cholera Prevention and Control. Summary conference proceedings, unpublished conference paper, March 15-16, 2012, Atlanta, GA.
31. Waldor MK, Hotez PJ, Clemens JD, 2010. A national cholera vaccine stockpile: a new humanitarian and diplomatic resource. N Engl J Med 363: 2279-2282.
32. Khatib AM, Ali M, von Seidlein L, Kim DR, Hashim R, Reyburn R, Ley B, Thriemer K, Enwere G, Hutubessy R, Aguado MT, Kieny MP, Lopez AL, Wierzba TF, Ali SM, Saleh AA, Mukhopadhyay AK, Clemens J, Jiddawi MS, Deen J, 2012. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study. Lancet Infect Dis 12: 837-844.
33. Longini IM Jr., Nizam A, Ali M, Yunus M, Shenvi N, Clemens JD, 2007. Controlling endemic cholera with oral vaccines. PLoS Med 4: e336.
34. Technical Advisory Group on Vaccine-Preventable Diseases, 2011. Final Report from the XIX TAG Meeting, July 6-8, 2011, Buenos Aires, Argentina.
35. Bulletin MSPP Janvier-Mars, 2013. Available at: http://issuu.com/jean- juniorjoseph/docs/bulletin-mspp-janvier-mars-2013-140513. Accessed August 4, 2013.
36. Djingarey MH, Barry R, Bonkoungou M, Tiendrebeogo S, Sebgo R, Kandolo D, Lingani C, Preziosi MP, Zuber PL, Perea W, Hugonnet S, Dellepiane de Rey Tolve N, Tevi-Benissan C, Clark TA, Mayer LW, Novak R, Messonier NE, Berlier M, Toboe D, Nshimirimana D, Mihigo R, Aguado T, Diomandé F, Kristiansen PA, Caugant DA, Laforce FM, 2012. Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Vaccine 30 (Suppl 2): B40-B45.
37. Ouandaogo CR, Yame'ogo TM, Diomandé FV, Sawadogo C, Oue'draogo B, Oue'draogo-Traoré R, Pezzoli L, Djingarey MH, Mbakuliyemo N, Zuber PL, 2012. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010. Vaccine 30 (Suppl 2): B46-B51.